The Department of Health and Social Care (DHSC) has issued a medicine supply notification for Temazepam 10mg and 20mg tablets.
“Temazepam 10mg and 20mg tablets are in limited supply until w/c 5th December 2022. Alternative benzodiazepines and non-benzodiazepine hypnotics remain available and will be able to support increased demand,” said DHSC.
Temazepam 10mg/5ml oral solution remains available but cannot support an uplift in demand. DHSC suggested: “Where the above options are not suitable, unlicensed supplies of temazepam 10mg tablets may be sourced, lead times vary.”
The department confirmed that Target Healthcare, a specialist importers, have confirmed they can source unlicensed Temazepam 10mg tablets.
“If there is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems an EPS prescription for unlicensed Temazepam 10mg tablets cannot be issued.”
Where a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘ Temazepam 10mg tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special with the following information:
- Amount dispensed over pack size used;
- Invoice price per pack size from which the order was supplied less any discount or rebate;
- Manufacturers’/importers’ MHRA licence number;
- Batch number of the product supplied;
- SP
DHSC and NHSE/I’s Medicines Supply Tool, provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
In rare cases, listeria can lead to serious complications such as meningitis and sepsis.Getty Images 
